Contact Us

DESTINATION NEWS

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Dec 10, 2024

SAN FRANCISCO and SUZHOU,China,Dec. 9,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

Dec 10, 2024

BEIJING,SHANGHAI and BOSTON,Dec. 9,2024-- Jacobio Pharma (1167.HK),a clinical-stage oncology company dedicated to developing therapies toward undruggable targets,today presented preliminary Phase I da

Researchers Highlight Urgent Need for Land Restoration and Food System Reforms to Protect Climate and Biodiversity

Dec 10, 2024

THUWAL,Saudi Arabia,Dec. 9,2024-- Researchers from KingAbdullah University of Science and Technology (KAUST),Saudi Arabia\'s leading applied research university,in collaboration with Aeon Collective,a

QNAP Announces Short-Depth Rackmount NAS TS-433eU with NPU Acceleration and Dual 2.5GbE

Dec 10, 2024

TAIPEI,Dec. 9,2024-- QNAP® Systems,Inc.,a leading computing and storage solutions innovator,today unveiled thecompact 1U rackmount 4-bay NAS TS-433eU,which offers small to midsize businesses and o

Phoenix Aviation Capital and AIP Capital Announce $240 Million Term Loan

Dec 10, 2024

The facility will support Phoenix and AIP with the purchase of six aircraft on-lease DUBLIN and STAMFORD,Conn.,Dec. 9,2024-- Phoenix Aviation Capital ("Phoenix"),a full-service aircraft le

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial

Dec 10, 2024

Late-stage trial in Alzheimer\'s opens 10 sites in US,with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer,Andrew Udell

1 ... 173 174 175 176 177 178 179 ... 337